Literature DB >> 11179481

Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.

S G Isler1, S Schenk, I Bendik, P Schraml, H Novotna, H Moch, G Sauter, C U Ludwig.   

Abstract

Human SPARC-like 1 (SPARCL1), also known as MAST9 or hevin, is a member of the SPARC protein family. Originally we identified SPARCL1 as one of the genes down regulated in human non-small cell lung cancer (NSCLC). Recent reports indicate that the down regulation of SPARCL1 also occurs in prostate and colon carcinomas, suggesting that SPARCL1 inactivation is a common event not only in NSCLCs but also in other tumors of epithelial origin. In the present work we report the cloning and mapping of the genomic locus of human SPARCL1. Using fluorescence in situ hybridization analysis, SPARCL1 was localized to chromosome 4q22-25, a region often deleted in human cancers. Furthermore, we show that the intron/exon organization of the human SPARCL1 gene is similar to its murine homologue SC1. SPARCL1 contains 11 exons and 10 introns which span approximately 47 kb of the genome. We also sequenced the 5'-flanking region of the human SPARCL1 gene containing 2.4 kb of the putative promoter region. The data presented herein are a prerequisite for deletion/mutation analysis of the SPARCL1 gene in tumors. In addition, knowledge of the SPARCL1 promoter sequence allows to investigate the regulation of SPARCL1 expression on the transcriptional level. Taken together our results will help to clarify the function of SPARCL1 in tumor formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179481     DOI: 10.3892/ijo.18.3.521

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  17 in total

1.  SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.

Authors:  Hong Zhang; Emma Widegren; Da-Wei Wang; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2011-09-02

2.  Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.

Authors:  Irene Esposito; Hany Kayed; Shereen Keleg; Thomas Giese; E Helene Sage; Peter Schirmacher; Helmut Friess; Jörg Kleeff
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

3.  Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling.

Authors:  James T Rosenbaum; Dongseok Choi; David J Wilson; Hans E Grossniklaus; Christina A Harrington; Cailin H Sibley; Roger A Dailey; John D Ng; Eric A Steele; Craig N Czyz; Jill A Foster; David Tse; Chris Alabiad; Sander Dubovy; Prashant K Parekh; Gerald J Harris; Michael Kazim; Payal J Patel; Valerie A White; Peter J Dolman; Bobby S Korn; Don O Kikkawa; Deepak P Edward; Hind M Alkatan; Hailah al-Hussain; R Patrick Yeatts; Dinesh Selva; Patrick Stauffer; Stephen R Planck
Journal:  Exp Mol Pathol       Date:  2015-07-08       Impact factor: 3.362

4.  An initial characterization of the serum phosphoproteome.

Authors:  Weidong Zhou; Mark M Ross; Alessandra Tessitore; David Ornstein; Amy Vanmeter; Lance A Liotta; Emanuel F Petricoin
Journal:  J Proteome Res       Date:  2009-12       Impact factor: 4.466

5.  Identification of genes differentially expressed in benign versus malignant thyroid tumors.

Authors:  Nijaguna B Prasad; Helina Somervell; Ralph P Tufano; Alan P B Dackiw; Michael R Marohn; Joseph A Califano; Yongchun Wang; William H Westra; Douglas P Clark; Christopher B Umbricht; Steven K Libutti; Martha A Zeiger
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

6.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Authors:  Feng Jiang; Zhengnan Yin; Nancy P Caraway; Ruiyun Li; Ruth L Katz
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

7.  SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma.

Authors:  Yang Yu; Yan Chen; Jianxia Ma; Xiaofeng Yu; Guanzhen Yu; Zhaoshen Li
Journal:  Tumour Biol       Date:  2015-10-21

8.  The inhibition of HeLa cells proliferation through SPARCL1 mediated by SPP1.

Authors:  Shengpeng Zhang; Fengge Zhang; Limin Feng
Journal:  Cytotechnology       Date:  2021-01-03       Impact factor: 2.058

9.  ECM2 and GLT8D2 in human pulmonary artery hypertension: fruits from weighted gene co-expression network analysis.

Authors:  Zeyang Bai; Lianyan Xu; Yong Dai; Qingchen Yuan; Zihua Zhou
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

10.  Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer.

Authors:  Oswaldo Keith Okamoto; Ana Carolina S R Carvalho; Luciana C Marti; Ricardo Z Vêncio; Carlos A Moreira-Filho
Journal:  Cancer Cell Int       Date:  2007-06-08       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.